Resistance to chemotherapy and molecularly targeted therapies: Rationale for combination therapy in malignant melanoma

Medicine and Dentistry

• Neoplasm 100%
• Nodular Melanoma 100%
• Combination Therapy 100%
• Molecularly Targeted Therapy 100%
• Melanoma Cell 50%
• Quality of Life 50%
• Therapy Resistance 50%
• Cytotoxic Chemotherapy 50%
• Metastatic Melanoma 50%
• Cytotoxic Agent 50%
• Survival Factor 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 100%
• Melanoma 100%
• Combination Therapy 100%
• Neoplasm 66%
• Therapy Resistance 33%
• Cytotoxic Agent 33%
• Metastatic Melanoma 33%
• Survival Factor 33%
• Cytotoxic Chemotherapy 33%

Keyphrases

• Molecular Inhibitors 50%
• Survival Impact 50%